Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0.01% atropine versus cyclopentolate for cycloplegic refraction in children
TCTR20260831002Phase 1Enrolling by invitation
- Sponsor
- Faculty of Medicine, Prince of Songkhla University
- Start
- Jun 2026
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of atropine and cyclopentolate in ametropia (2 arms), sponsored by Faculty of Medicine, Prince of Songkhla University. Primary endpoints: Spherical equivalent after cyclopentolate at 30 minutes, Spherical equivalent after atropine at 60 minutes and 1 more. Started Jun 2026; status: enrolling by invitation.
02
Drugs
atropinecyclopentolate
03
Conditions
ametropia
Beyond the preview
Go deeper on TCTR20260831002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260831002.